Skip to content

Clinical trials

Terminated Multiple Myeloma trials in Israel

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Terminated Country / region: Israel Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20091
20161
20172
20191
20202
20211
20222
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated14

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AbbVie2
Teva Branded Pharmaceutical Products R&D LLC2
AEterna Zentaris1
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
European Society for Blood and Marrow Transplantation1
Oncopeptides AB1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma14
Recurrence3
Leukemia, Myeloid, Acute2
Lymphoma, Non-Hodgkin2
Neoplasms2
Blast Crisis1
Burkitt Lymphoma1
Congenital Abnormalities1
Fever1
Hodgkin Disease1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.